Programmable genome editing in human cells using RNA-guided bridge recombinases
Science · 2026
DOI: 10.1126/science.adz1884 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science, 2026. Verfasst von Oana Pelea und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, University of Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Gene Editing, DNA Nucleotidyltransferases, Recombinases, RNA, Guide, CRISPR-Cas Systems. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: European Molecular Biology Organization, H2020 European Research Council, Swiss National Science Foundation.
Abstract (Originalsprache)
Site-specific insertion of gene-sized DNA fragments remains an unmet need in the field of genome editing. IS110-family serine recombinases have recently been shown to mediate programmable DNA recombination in bacteria by using a bispecific RNA guide (bridge RNA) that simultaneously recognizes target and donor sites. In this work, we have shown that the bridge recombinase ISCro4 is highly active in human cells and provided structural insights into its enhanced activity. Using plasmid- or all-RNA–based delivery, ISCro4 supports programmable multikilobase excisions and inversions and facilitates donor DNA insertion at genomic sites with efficiencies that exceed 6%. Last, we assessed ISCro4 specificity and off-target activity. These results establish a framework for the development of bridge recombinases as next-generation tools for editing modalities that are beyond the capabilities of current technologies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, University of Zurich, Zurich, Switzerland.
- Institute of Pharmacology and Toxicology, University of Zurich, Zurich, Switzerland.
- Institute of Molecular Health Sciences, Swiss Federal Institute of Technology (ETH Zürich), Zurich, Switzerland.
ORCID-Profile: Oana Pelea, András Tálas, Nicolas Mathis, Lilly van de Venn, Charles D Yeh, Péter I Kulcsár, Kim F Marquart, Yanik Weber, Saskia E Gerecke, Isabelle F Harvey-Seutcheu, Dominic Mailänder, Moritz M Pfleiderer, Christelle Chanez, Jacob E Corn, Gerald Schwank, Martin Jinek
Förderung
- European Molecular Biology Organization
- H2020 European Research Council
- Swiss National Science Foundation
- European Research Council
- Swiss State Secretariat for Education, Research and Innovation
Zitieren
APA
Pelea, O., Tálas, A., Carrera, J. F., Mathis, N., van de Venn, L., Yeh, C. D., Kulcsár, P. I., Marquart, K. F., Weber, Y., Gerecke, S. E., Harvey-Seutcheu, I. F., Mailänder, D., Pfleiderer, M. M., Chanez, C., Corn, J. E., Schwank, G., & Jinek, M. (2026). Programmable genome editing in human cells using RNA-guided bridge recombinases. Science. https://doi.org/10.1126/science.adz1884
Vancouver
Pelea O, Tálas A, Carrera JF, Mathis N, van de Venn L, Yeh CD, et al. Programmable genome editing in human cells using RNA-guided bridge recombinases. Science. 2026. doi:10.1126/science.adz1884
BibTeX
@article{Pelea2026,
author = {Pelea, Oana and Tálas, András and Carrera, Javier Fernández and Mathis, Nicolas and van de Venn, Lilly and Yeh, Charles D and Kulcsár, Péter I and Marquart, Kim F and Weber, Yanik and Gerecke, Saskia E and Harvey-Seutcheu, Isabelle F and Mailänder, Dominic and Pfleiderer, Moritz M and Chanez, Christelle and Corn, Jacob E and Schwank, Gerald and Jinek, Martin},
title = {Programmable genome editing in human cells using RNA-guided bridge recombinases},
journal = {Science},
year = {2026},
doi = {10.1126/science.adz1884}
}
EUVIMED